Table 3. SARS-CoV-2 infection attack rates (%) by symptoms and age category in schools in a city in northern France, 13 January–19 April 2020 (n = 2,004 participants).
Symptoms | Children < 12 years (n = 546) | Children 12–17 years (n = 313) | Adults (n = 1,145) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Number of individuals |
Proportion with the symptom (%) |
Number infected | Proportion with the symptom infected (%) |
p value | Number of individuals |
Proportion with the symptom (%) |
Number infected | Proportion with the symptom infected (%) |
p value | Number of individuals |
Proportion with the symptom (%) |
Number infected | Proportion with the symptom infected (%) |
p value | |
Fever | |||||||||||||||
Yes | 121 | 22.2 | 13 | 10.7 | 0.30 | 84 | 26.8 | 33 | 39.3 | 0.03 | 254 | 22.2 | 81 | 31.9 | < 0.001 |
No | 425 | 77.8 | 33 | 7.8 | 229 | 73.2 | 61 | 26.6 | 891 | 77.8 | 85 | 9.5 | |||
Cough | |||||||||||||||
Yes | 124 | 22.7 | 8 | 6.5 | 0.37 | 105 | 32.9 | 32 | 30.5 | 0.90 | 349 | 30.5 | 87 | 24.9 | < 0.001 |
No | 422 | 77.3 | 38 | 9.0 | 208 | 66.5 | 62 | 29.8 | 796 | 69.5 | 79 | 9.9 | |||
Dyspnoea | |||||||||||||||
Yes | 20 | 3.7 | 3 | 15.0 | 0.28 | 33 | 10.5 | 5 | 15.1 | 0.05 | 157 | 13.7 | 49 | 31.2 | < 0.001 |
No | 526 | 96.3 | 43 | 8.2 | 280 | 89.5 | 89 | 31.8 | 988 | 86.3 | 117 | 11.8 | |||
Ageusia | |||||||||||||||
Yes | 4 | 0.7 | 0 | 0 | 0.99 | 19 | 6.1 | 17 | 89.5 | < 0.001 | 94 | 8.2 | 76 | 80.9 | < 0.001 |
No | 542 | 99.3 | 46 | 8.5 | 294 | 93.9 | 77 | 26.2 | 1,051 | 91.7 | 90 | 8.6 | |||
Anosmia | |||||||||||||||
Yes | 2 | 0.4 | 0 | 0 | 0.99 | 20 | 6.4 | 16 | 80.0 | < 0.001 | 85 | 7.4 | 76 | 89.4 | < 0.001 |
No | 544 | 99.6 | 46 | 8.5 | 293 | 93.6 | 78 | 26.6 | 1,060 | 92.6 | 90 | 8.5 | |||
Myalgia | |||||||||||||||
Yes | 40 | 7.3 | 4 | 10.0 | 0.71 | 55 | 17.6 | 19 | 34.5 | 0.42 | 268 | 23.4 | 83 | 31.0 | < 0.001 |
No | 506 | 92.7 | 42 | 8.3 | 258 | 82.4 | 75 | 29.1 | 877 | 76.6 | 83 | 9.5 | |||
Sore throat | |||||||||||||||
Yes | 90 | 16.5 | 8 | 8.9 | 0.86 | 87 | 27.8 | 25 | 28.7 | 0.76 | 261 | 22.8 | 53 | 20.3 | 0.002 |
No | 456 | 83.5 | 38 | 8.3 | 226 | 72.2 | 69 | 30.5 | 884 | 77.2 | 113 | 12.8 | |||
Rhinorrhoea | |||||||||||||||
Yes | 97 | 17.8 | 10 | 10.3 | 0.46 | 114 | 36.4 | 41 | 36.0 | 0.08 | 283 | 24.7 | 62 | 21.9 | < 0.001 |
No | 449 | 82.2 | 36 | 8.0 | 199 | 63.5 | 53 | 26.6 | 862 | 75.3 | 104 | 12.1 | |||
Headache | |||||||||||||||
Yes | 101 | 18.5 | 8 | 7.9 | 0.84 | 91 | 29.1 | 31 | 34.1 | 0.32 | 332 | 29.0 | 84 | 25.3 | < 0.001 |
No | 445 | 81.5 | 38 | 8.5 | 222 | 70.9 | 63 | 28.4 | 813 | 71.0 | 82 | 10.1 | |||
Asthenia | |||||||||||||||
Yes | 79 | 14.4 | 11 | 13.9 | 0.06 | 77 | 24.6 | 26 | 33.8 | 0.41 | 350 | 30.6 | 95 | 27.1 | < 0.001 |
No | 467 | 85.5 | 35 | 7.5 | 236 | 75.4 | 68 | 28.8 | 795 | 69.4 | 71 | 8.9 | |||
Chest pain | |||||||||||||||
Yes | 0 | 0 | 0 | 0 | NA | 0 | 0 | 0 | 0 | - | 7 | 0.6 | 0 | 0 | 0.61 |
No | 546 | 100 | 46 | 8.4 | 313 | 100 | 94 | 30.0 | 1,138 | 99.4 | 166 | 14.6 | |||
Nausea | |||||||||||||||
Yes | 3 | 0.5 | 1 | 33.3 | 0.23 | 3 | 1.0 | 2 | 66.7 | 0.22 | 10 | 0.9 | 4 | 40.0 | 0.04 |
No | 543 | 99.5 | 45 | 8.3 | 310 | 99.0 | 92 | 29.7 | 1,135 | 99.1 | 162 | 14.3 | |||
Vomiting | |||||||||||||||
Yes | 23 | 4.2 | 1 | 4.3 | 0.71 | 13 | 4.2 | 5 | 38.5 | 0.54 | 18 | 1.6 | 2 | 11.1 | 0.99 |
No | 523 | 95.8 | 45 | 8.6 | 300 | 95.8 | 89 | 29.7 | 1,127 | 98.4 | 164 | 14.6 | |||
Abdominal pain | |||||||||||||||
Yes | 6 | 1.1 | 0 | 0 | 0.99 | 2 | 0.6 | 0 | 0 | 0.99 | 12 | 1.0 | 4 | 33.3 | 0.08 |
No | 540 | 98.9 | 46 | 8.5 | 311 | 99.4 | 94 | 30.2 | 1,133 | 99.0 | 162 | 14.3 | |||
Diarrhoea | |||||||||||||||
Yes | 50 | 9.2 | 9 | 18.0 | 0.01 | 37 | 11.8 | 17 | 45.9 | 0.03 | 151 | 13.2 | 38 | 25.2 | < 0.001 |
No | 496 | 90.8 | 37 | 7.5 | 276 | 88.2 | 77 | 27.9 | 994 | 86.8 | 128 | 12.9 | |||
Symptom severity | |||||||||||||||
None | 274 | 50.2 | 20 | 7.3 | 0.62 | 110 | 35.1 | 22 | 20.0 | 0.01 | 429 | 37.5 | 14 | 3.3 | < 0.001 |
Minora only | 89 | 16.3 | 8 | 9.0 | 54 | 17.3 | 15 | 27.8 | 214 | 18.7 | 14 | 6.5 | |||
Majorb | 183 | 33.5 | 18 | 9.8 | 149 | 47.6 | 57 | 38.3 | 502 | 43.8 | 138 | 27.5 | |||
Medical consultationc | |||||||||||||||
Yes | 99 | 36.4 | 8 | 8.1 | 0.53 | 44 | 21.7 | 17 | 38.6 | 0.62 | 255 | 35.6 | 73 | 28.6 | < 0.001 |
No | 173 | 63.6 | 18 | 10.4 | 159 | 78.3 | 55 | 34.6 | 461 | 64.4 | 79 | 17.1 | |||
Hospitalisation | |||||||||||||||
Yes | 1 | 0.2 | 0 | 0 | 0.99 | 4 | 1.3 | 2 | 50.0 | 0.59 | 14 | 1.2 | 9 | 64.3 | < 0.001 |
No | 545 | 99.8 | 46 | 8.5 | 309 | 98.7 | 92 | 29.8 | 1,131 | 98.8 | 157 | 13.9 |
NA: not applicable.
a Minor symptoms included asthenia, diarrhoea, headache, myalgia, rhinitis, and sore throat.
b Major symptoms included ageusia and anosmia, fever, dry cough and dyspnoea.
c Only among participants who declared symptoms, including children < 12 years (n = 272); children 12–17 years (n = 203); adults (n = 716).